Literature DB >> 22362833

The potential of telehealth for 'business as usual' in outpatient clinics.

Karen Day1, Patricia Kerr.   

Abstract

A six-month pilot study was conducted to ascertain the value of using high-definition videoconferencing equipment in an outpatients' setting. The videoconferencing equipment, which included digital biometric equipment, was installed in the outpatient clinics of a remote health service in New Zealand. Use of the equipment was evaluated using action research techniques. Clinicians were interviewed about their assessment of the equipment's usefulness. Patients and their carers completed questionnaires about their clinic experience. During the pilot trial, 109 patients were seen in 25 clinics of six different specialities. Questionnaire results showed that patients and their companions had a good user experience, similar to a face-to-face appointment. Clinicians found that the large screen, sense of proximity, video clarity and definition, and lack of sound/picture lag worked well for certain types of outpatients' clinics, e.g. methadone maintenance clinics. The need for process changes made it difficult to turn telehealth into business as usual in an environment built for face-to-face appointments. We conclude that videoconference equipment has potential to become integral to outpatients' clinics.

Entities:  

Mesh:

Year:  2012        PMID: 22362833     DOI: 10.1258/jtt.2012.SFT104

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  2 in total

1.  Survey protocol for exploring video and phone use in Aotearoa New Zealand general practice: considerations for future telehealth.

Authors:  Karen Day; Inga Hunter; Vasudha Rao; Greig Russell; Rachel Roskvist; Fiona Moir; Emily Gill; Bert van der Werf
Journal:  BMJ Health Care Inform       Date:  2021-03

Review 2.  Best Practices and Lessons Learned for Action Research in eHealth Design and Implementation: Literature Review.

Authors:  Kira Oberschmidt; Christiane Grünloh; Femke Nijboer; Lex van Velsen
Journal:  J Med Internet Res       Date:  2022-01-28       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.